Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.58 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.49 |
| ▸ | GSR | P00390 | 1/20 | 0.46 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.44 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.43 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.43 |
| ▸ | CPB2 | Q96IY4 | 10/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | GNPAT | O15228 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL45765 | 1.00 | FOLH1 (0.58) | FOLH1SLC6A5GSRRNPEPSIRT6 | |
| Hydrochloric Acid SCHEMBL2166126 | 0.98 | FOLH1 (0.57) | FOLH1SLC6A5GSRRNPEPSIRT6 | |
| Hydrochloric Acid SCHEMBL15914484 | 0.98 | FOLH1 (0.57) | FOLH1SLC6A5GSRRNPEPSIRT6 | |
| Acetic Acid SCHEMBL268740 | 0.98 | FOLH1 (0.57) | FOLH1SLC6A5GSRRNPEPSIRT6 | |
| SCHEMBL867577 | 0.95 | FOLH1 (0.51) | FOLH1SLC6A5GSRRNPEPSIRT6 | |
| SCHEMBL866580 | 0.95 | FOLH1 (0.51) | FOLH1SLC6A5GSRRNPEPSIRT6 | |
| SCHEMBL232125 | 0.95 | FOLH1 (0.51) | FOLH1SLC6A5GSRRNPEPSIRT6 | |
| Hydrochloric Acid SCHEMBL1982438 | 0.93 | FOLH1 (0.50) | FOLH1SLC6A5GSRSIRT6SIRT1 | |
| Hydrochloric Acid SCHEMBL1982441 | 0.93 | FOLH1 (0.50) | FOLH1SLC6A5GSRSIRT6SIRT1 | |
| SCHEMBL919220 | 0.85 | FOLH1 (0.62) | FOLH1SLC6A5GSRRNPEPSIRT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140154207-A1 | KIT CONTAINING STEM CELLS AND CYTOKINES FOR USE IN ATTENUATING IMMUNE RESPONSES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2014-06-05 | — | — | US | claimed |
| US-20130123364-A1 | N6-(1-IMINOETHYL)-L-LYSINE FOR REGENERATION OF ALVEOLI IN LUNGS | WEISSMANN NORBERT (DE) | 2013-05-16 | — | — | US | claimed |
| US-8183409-B2 | High yield and rapid synthesis methods for producing metallo-organic salts | OSTEOLOGIX A/S (DK) | 2012-05-22 | — | — | US | claimed |
| US-8088150-B2 | Device for disc shunt implantation and peri-shunt injection | ALEEVA MEDICAL INC. (US) | 2012-01-03 | — | — | US | claimed |
| US-20090325858-A1 | Reduction of Zinc-Induced Neurotoxic Injury By Blockade of Nitric Oxide Synthesis | ANDRO DIAGNOSTICS, INC. (US) | 2009-12-31 | — | — | US | claimed |
| US-20090291926-A1 | HIGH YIELD AND RAPID SYNTHESIS METHODS FOR PRODUCING METALLO-ORGANIC SALTS | CHRISTGAU STEPHAN | 2009-11-26 | — | — | US | claimed |
| US-20090198248-A1 | Device for disc shunt implantation and peri-shunt injection | YEUNG JEFFREY E | 2009-08-06 | — | — | US | claimed |
| US-20080317849-A1 | Method for Improving the Medical Treatment of Pain | OSTEOLOGIX A/S (DK) | 2008-12-25 | — | — | US | claimed |
| EP-1534313-A4 | OPHTHALMOLOGIC IRRIGATION SOLUTIONS AND METHOD | OMEROS CORP (US) | 2008-06-25 | — | — | EP | claimed |
| US-20070282127-A1 | High Yield And Rapid Synthesis Methods For Producing Metallo-Organic Salts | OSTEOLOGIX A/S | 2007-12-06 | — | — | US | claimed |
| US-5686567-A | OLIGOPEPTIDES, SNAKE VENOM | COR THERAPEUTICS, INC. (US) | 1997-11-11 | — | — | US | claimed |
| WO-1997032585-A1 | COMBINATIONAL THERAPEUTIC METHODS EMPLOYING NITRIC OXIDE SCAVENGERS AND COMPOSITIONS USEFUL THEREFOR | MEDINOX, INC. (US) | 1997-09-12 | — | — | WO | claimed |
| WO-1997018805-A1 | COMBINATIONAL THERAPEUTIC METHODS EMPLOYING NITRIC OXIDE SCAVENGERS | MEDINOX, INC. (US) | 1997-05-29 | — | — | WO | claimed |
| EP-0751219-A1 | Platelet aggregation inhibitors | COR THERAPEUTICS, INC. (US) | 1997-01-02 | — | — | EP | claimed |
| EP-0477295-B1 | PLATELET AGGREGATION INHIBITORS | COR THERAPEUTICS INC (US) | 1997-01-02 | — | — | EP | claimed |
| EP-0639202-A1 | STABLE POLYPEPTIDE COMPOSITION | COR THERAPEUTICS, INC. (US) | 1995-02-22 | — | — | EP | claimed |
| WO-1993022335-A1 | STABLE POLYPEPTIDE COMPOSITION | COR THERAPEUTICS, INC. (US) | 1993-11-11 | — | — | WO | claimed |
| EP-0477295-A4 | PLATELET AGGREGATION INHIBITORS | — | 1992-10-07 | — | — | EP | claimed |
| EP-0477295-A1 | PLATELET AGGREGATION INHIBITORS. | COR THERAPEUTICS INC (US) | 1992-04-01 | — | — | EP | claimed |
| WO-1990015620-A1 | PLATELET AGGREGATION INHIBITORS | COR THERAPEUTICS, INC. (US) | 1990-12-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130123364-A1 | N6-(1-IMINOETHYL)-L-LYSINE FOR REGENERATION OF ALVEOLI IN LUNGS | PRMT1, ARG1, ARGLU1 | FOLH1 1155/4885SLC6A5 3250/4885GSR 2375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.